UK markets closed

Werewolf Therapeutics, Inc. (HOWL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.1600-0.1900 (-8.09%)
As of 12:12PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
16,221
19,943
16,401
0
0
-
Operating expenses
Research development
42,978
41,776
53,761
35,269
16,641
-
Selling general and administrative
18,685
18,670
18,696
14,818
5,763
-
Total operating expenses
61,663
60,446
72,457
50,087
22,404
-
Operating income or loss
-45,442
-40,503
-56,056
-50,087
-22,404
-
Interest expense
3,970
3,139
0
-
-
-
Total other income/expenses net
-37
-1,142
338
-
7,301
60
Income before tax
-41,579
-37,368
-53,810
-49,983
-15,040
-
Income from continuing operations
-41,579
-37,368
-53,810
-49,983
-15,040
-
Net income
-41,579
-37,368
-53,810
-49,983
-15,040
-
Net income available to common shareholders
-41,579
-37,368
-53,810
-201,925
-28,217
-
Basic EPS
-1.10
-1.05
-1.86
-10.94
-3.15
-
Diluted EPS
-1.10
-1.05
-1.86
-10.94
-3.15
-
Basic average shares
34,191
35,647
28,864
18,455
8,971
-
Diluted average shares
34,191
35,647
28,864
18,455
8,971
-